Adiponectin; Apolipoprotein, A1; Apolipoprotein; C-Reactive Protein; Cholesterol; Creatinine; Cystatin C; Glucose; Glycomark (1,5-AG); HDL; Homocysteine; Insulin; LDL; Leptin; Adiponectin ratio; Leptin; Lipoprotein (a); Oxidized LDL; PLAC (LP-PLA2 Activity); Triglycerides; small dense LDL
CardioMetabolic Profile, Serum
Test
Report Includes
Specimens
Serum
Clinical Utility
This advanced test evaluates risk factors for cardiovascular disease (CVD) plus metabolic factors associated with metabolic syndrome and type II diabetes. In addition to the traditional CVD risk factors, the test includes much more clinically sensitive atherogenic lipoprotein sub-species, the primary apolipoproteins, arterial inflammation and the activity of the lipoprotein- associated phospholipase- A2 (PLAC). PLAC activity is a very sensitive indicator of active atherogenesis and instability of advanced arterial plaque. Metabolic syndrome (MetS) is centered around insulin resistance and atherogenic dyslipoproteinemia, and is a risk factor associated with CVD and kidney disease. The test includes cystatin C to better assess glomerular filtration, and 1,5-anhydroglucitol (Glycomark) that is a better indicator of hyperglycemic episodes than HbA1C. The primary adipokines associated with insulin sensitivity and hepatic fatty acid metabolism are also addressed
Source: https://www.doctorsdata.com/cardiometabolic-profile-serum/;Accessed 23-May-2019
Test Location
Doctor's Data, IL, USA
Test Version
30-Sep-2019
Specimen
Specimens
Serum
Additional Information
This test kit is provided by ICL Client Care. To order a kit, or for more information, please email info@iclabs.ca or call 416-422-3000 ext 300
For additional information refer to the Doctors Data websiteCardiometabolic Profile
Rejection Criteria
Hemolysis | Present |
---|
Test Version
30-Sep-2019
Performance / Interpretation
Turnaround Time
7 Days
Sample Reports
Test Location
Doctor's Data, IL, USA
Test Version
30-Sep-2019